APAC Molecular Diagnostics Market, Forecast to 2021

Pharmerging Economies with Rising Healthcare Demands will Accentuate Growth

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

The molecular diagnostics (MDx) market in APAC is witnessing rapid growth due to two main factors: the high adoption of MDx tests for infectious diseases applications in emerging countries, and the advent of innovative diagnostic solutions in cancer and NGS based solutions that are gaining pace in Asia. Multinational companies have not only identified Asia as a market for future growth but have significantly invested in R&D efforts to cater to the Asian population. Genomic studies on Asian population in disease areas like oncology for targeted therapies are constantly on a rise, with active efforts from pharmaceutical and IVD companies. The rise of the private healthcare sector in Asia, with the improvement of socio-economic conditions and the growth of a wealthy middle class, has increased the quest for affordable and quality healthcare across the region.

The total MDx industry has been segmented into 4 major areas: infectious diseases, oncology, genetic disorders, and pharmacogenomics. The APAC MDx market was worth $1.72 Billion in 2016 and is expected to reach $2.86 Billion by 2021, at a CAGR of 10.7%. Infectious disease represents the highest market share of 72.0%, followed by oncology (14.3%), genetic disorders (10.0%) and pharmacogenomics (3.7%).

Cancer incidence has gone up significantly in Asia. Under genetic disorders, non-invasive prenatal testing (NIPT) has great potential with excellent opportunities for future growth. On the technology front, conventional PCR technology is being upgraded with multiplexing capabilities and introduction of automated solutions to cater to high volumes. NGS solutions are gradually making inroads into Asia, especially in developed markets like Singapore, Japan, and South Korea.

This study highlights the growing prominence of MDx industry in Asia, regional trends, growth opportunities, competitive dynamics, and a regional chapter for each of the 11 countries covered in this study.

Area of opportunity in MDx market in the APAC:
• The MDx market in the APAC is evolving with increasing access to established NATs in emerging countries as a result of revamped healthcare practices across the region.
• Oncology care has taken a new dimension in APAC, with the simultaneous rise in prevalence and demand for innovative drugs beyond conventional chemotherapy drugs.
• CDx based oncology drugs are on the rise in the region, with studies targeted for Asian population to demonstrate value. For example, Ono Pharmaceutical’s research on identifying a CDx for Opdivo, introduced in 2014 to stratify patient population.
• Novel genomic tools and technologies are foraying into the APAC to harness the future growth opportunities in the dynamic healthcare ecosystem.

Key questions this study will answer:
• What is the impact of MDx on the IVD industry, given the present healthcare scenario in the APAC?
• Who are the key industry participants in this highly fragment market?
• What are multiple factors impending the growth of MDx in the APAC?
• What are the service delivery models adapted by stakeholders across this region?
• What are the market access strategies for MDx companies aspiring to enter the APAC?
• What is the future of the molecular diagnostics market in the APAC?

Table of Contents

Forecast Methodology
1. Executive Summary
Key Findings
Scope and Segmentation
Market Engineering Measurements
Market Overview—Definitions
8 Big Market Themes for APAC MDx
Trends/Factors Impacting the APAC MDx Market
Key Companies to Watch
Key Predictions
MDx—Transition from Present to Future
2. Market Overview
Market Segmentation
Infectious Disease
Pharmacogenomics
Oncology
Genetic Disorders
Market Overview—Segmentation by Application
Role of Molecular Biomarkers in Pharma R&D
Market Overview—Life Cycle Analysis
3. Competitive Playbook
Key Mergers, Acquisitions, & Partnerships
4. Drivers and Restraints—Total Molecular Diagnostics Market
Market Drivers
Rise in OOP payments and demand for quality healthcare increase in public healthcare spending and public awareness increases test volume in healthcare settings
High incidence of communicable and non-communicable diseases increases the opportunity for diagnostics tests
Focus on preventive healthcare, voluntary diagnostic tests, and payer initiatives to reduce healthcare costs by early stage diagnostics
Market Restraints
Burgeoning healthcare costs; federal initiatives to strengthen primary care to reduce utilization of secondary resources (eg. hospital admission, diagnostic tests)
Lack of harmonized reimbursement protocols, regulatory standards, and stringent market access protocols
High cost involved in sophisticated MDx tests; operational and infrastructure costs
5. Forecast and Trends—Total Molecular Diagnostics Market
Market Engineering Measurements
Total Molecular Diagnostics Market—Revenue Forecast
Percent Revenue Forecast by Country
Revenue Forecast by Country
Snapshot of Market Participants
Market Snapshot
6. Competitive Environment
Market Share by Companies
Roche
Illumina
Thermofisher
Agilent
BGI
Abbott
Qiagen
Others
Competitive Positioning—Seegene
Competitive Positioning—Roche
Competitive Positioning—ThermoFisher
Competitive Positioning—Qiagen
Competitive Positioning—Sysmex
7. Growth Opportunities
Growth Opportunities—Synergy of 3Ps in APAC
Growth Opportunities—Clinical Trials Market in APAC
Growth Opportunities
Trends for the Adoption of MDx Services in APAC
Future Trends—Direct to Consumer Testing
Future Trends—Niche Clusters to Watch Out for
Future Trends—Point-of-Care Testing (POCT) in MDx
Future Trends—Lifestyle Genomics in APAC
Genome Asia-100K
8. Technology Segments—An Overview
Polymerase Chain Reaction (PCR)
PCR—Technology Snapshot
In-situ Hybridization (ISH)
Next-Generation Sequencing (NGS)
Cost Implications of NGS
Future of NGS Platform
Drivers for Technology Platforms
MDx Test by Application Scenarios
9. Clinical Application Segment Analysis—Infectious Disease Segment
Infectious Disease Segment—Revenue Forecast
10. Oncology Segment
Oncology Segment—Revenue Forecast
11. Genetic Disorders Segment
Genetic Disorders Segment—Revenue Forecast
12. Pharmacogenomics Segment
Pharmacogenomics Segment—Revenue Forecast
13. Regional Forecast Trends and Opportunities— China Molecular Diagnostics Market
Market Engineering Measurements
China Market—Revenue Forecast
China—Market Drivers
China—Market Restraints
Competitive Structure
14. South Korea Molecular Diagnostics Market
Market Engineering Measurements
South Korea Market—Revenue Forecast
South Korea—Market Drivers
South Korea—Market Restraints
Competitive Structure
15. India Molecular Diagnostics Market
Market Engineering Measurements
India Market—Revenue Forecast
India—Market Drivers
India—Market Restraints
India—Market Restraints
16. Japan Molecular Diagnostics Market
Market Engineering Measurements
Japan Market—Revenue Forecast
Japan—Market Drivers
Japan—Market Restraints
Competitive Structure
17. Australia Molecular Diagnostics Market
Market Engineering Measurements
Australia Market—Revenue Forecast
Australia—Market Drivers
Australia—Market Restraints
Competitive Structure
18. Taiwan Molecular Diagnostics Market
Market Engineering Measurements
Taiwan Market—Revenue Forecast
Taiwan—Market Drivers
Taiwan—Market Restraints
Competitive Structure
19. Indonesia Molecular Diagnostics Market
Market Engineering Measurements
Indonesia Market—Revenue Forecast
Indonesia—Market Drivers
Indonesia—Market Restraints
Competitive Structure
20. Malaysia Molecular Diagnostics Market
Market Engineering Measurements
Malaysia Market—Revenue Forecast
Malaysia—Market Drivers
Malaysia—Market Restraints
Competitive Structure
Key Trends—Challenges and Opportunities
21. Thailand Molecular Diagnostics Market
Market Engineering Measurements
Thailand Market—Revenue Forecast
Thailand—Market Drivers
Thailand—Market Restraints
Competitive Structure
22. Singapore Molecular Diagnostics Market
Market Engineering Measurements
Singapore Market—Revenue Forecast
Singapore—Market Drivers
Singapore—Market Restraints
Competitive Structure
23. Philippines Molecular Diagnostics Market
Market Engineering Measurements
Philippines Market—Revenue Forecast
Philippines—Market Drivers
Philippines—Market Restraints
Competitive Structure
24. Vietnam Molecular Diagnostics Market
Market Engineering Measurements
Vietnam Market—Revenue Forecast
Vietnam—Market Drivers
Vietnam—Market Restraints
Competitive Structure
25. Conclusion
The Last Word—Three Big Predictions
Key Conclusions
Legal Disclaimer
26. Appendix
Market Engineering Methodology

Infographic



List of Figures & Charts

1. Total Molecular Diagnostics Market: Key Market Drivers, APAC, 2017–2021
2. Total Molecular Diagnostics Market: Key Market Restraints, APAC, 2017–2021
3. Total Molecular Diagnostics Market: Market Engineering Measurements, APAC, 2016
4. Total Molecular Diagnostics Market: Revenue Forecast by Country, APAC, 2014–2021
5. Total Molecular Diagnostics Market: POCT Platforms and Assay Availability by Top Manufacturers, APAC, 2016
6. Total Molecular Diagnostics Market: PCR Platforms from Major Companies, APAC, 2016
7. Total Molecular Diagnostics Market: Companion Diagnostic Tests for Different Cancer Types, APAC, 2016
8. Total Molecular Diagnostics Market: Comparison of Sanger Sequencing and NGS, APAC, 2016
9. Total Molecular Diagnostics Market: Overview of Technology Platforms in MDx, APAC, 2016
10. Molecular Diagnostics Industry: Market Engineering Measurements, China, 2016
11. Molecular Diagnostics Market: Drivers, China, 2017–2021
12. Molecular Diagnostics Market: Restraints, China, 2017–2021
13. Molecular Diagnostics Market: Competitive Structure, China, 2016
14. Molecular Diagnostics Market: Market Engineering Measurements, South Korea, 2016
15. Molecular Diagnostics Market: Drivers, South Korea, 2017–2021
16. Molecular Diagnostics Market: Restraints, South Korea, 2017–2021
17. Molecular Diagnostics Market: Competitive Structure, South Korea, 2016
18. Molecular Diagnostics Market: Market Engineering Measurements, India, 2016
19. Molecular Diagnostics Market: Drivers, India, 2017–2021
20. Molecular Diagnostics Market: Restraints, India, 2017–2021
21. Molecular Diagnostics Market: Competitive Structure, India, 2016
22. Molecular Diagnostics Market: Market Engineering Measurements, Japan, 2016
23. Molecular Diagnostics Market: Drivers, Japan, 2017–2021
24. Molecular Diagnostics Market: Restraints, Japan, 2017–2021
25. Molecular Diagnostics Market: Competitive Structure, Japan, 2016
26. Molecular Diagnostics Market: Market Engineering Measurements, Australia, 2016
27. Molecular Diagnostics Market: Drivers, Australia, 2017–2021
28. Molecular Diagnostics Market: Restraints, Australia, 2017–2021
29. Molecular Diagnostics Market: Competitive Structure, Australia, 2016
30. Molecular Diagnostics Market: Market Engineering Measurements, Taiwan, 2016
31. Molecular Diagnostics Market: Drivers, Taiwan, 2017–2021
32. Molecular Diagnostics Market: Restraints, Taiwan, 2017–2021
33. Molecular Diagnostics Market: Restraints, Taiwan, 2017–2021
34. Molecular Diagnostics Market: Market Engineering Measurements, Indonesia, 2016
35. Molecular Diagnostics Market: Drivers, Indonesia, 2017–2021
36. Molecular Diagnostics Market: Restraints, Indonesia, 2017–2021
37. Molecular Diagnostics Market: Competitive Structure, Indonesia, 2016
38. Molecular Diagnostics Market: Market Engineering Measurements, Malaysia, 2016
39. Molecular Diagnostics Market: Drivers, Malaysia, 2017–2021
40. Molecular Diagnostics Market: Restraints, Malaysia, 2017–2021
41. Molecular Diagnostics Market: Competitive Structure, Malaysia, 2016
42. Molecular Diagnostics Market: Market Engineering Measurements, Thailand, 2016
43. Molecular Diagnostics Market: Drivers, Thailand, 2017–2021
44. Molecular Diagnostics Market: Restraints, Thailand, 2017–2021
45. Molecular Diagnostics Market: Competitive Structure, Thailand, 2016
46. Molecular Diagnostics Market: Market Engineering Measurements, Singapore, 2016
47. Molecular Diagnostics Market: Drivers, Singapore, 2017–2021
48. Molecular Diagnostics Market: Restraints, Singapore, 2017–2021
49. Molecular Diagnostics Market: Competitive Structure, Singapore, 2016
50. Molecular Diagnostics Market: Market Engineering Measurements, Philippines, 2016
51. Molecular Diagnostics Market: Drivers, Philippines, 2017–2021
52. Molecular Diagnostics Market: Restraints, Philippines, 2017–2021
53. Molecular Diagnostics Market: Competitive Structure, Philippines, 2016
54. Molecular Diagnostics Market: Market Engineering Measurements, Vietnam, 2016
55. Molecular Diagnostics Market: Drivers, Vietnam, 2017–2021
56. Molecular Diagnostics Market: Restraints, Vietnam, 2017–2021
57. Molecular Diagnostics Market: Competitive Structure, Vietnam, 2016


1. Total Molecular Diagnostics Market: Market Engineering Measurements, APAC, 2016
2. Total Molecular Diagnostics Market: Roles of Biomarkers in the Pharmaceutical Value Chain, APAC, 2016
3. Total Molecular Diagnostics Market: Future of Molecular Diagnostics Industry, APAC, 2016
4. Total Molecular Diagnostics Market: Percent Revenue Breakdown by Application, APAC, 2016
5. Total Molecular Diagnostics Market: Roles of Biomarkers in Pharmaceutical Value Chain, APAC, 2016
6. Total Molecular Diagnostics Market: Life Cycle Analysis, APAC, 2016
7. Total Molecular Diagnostics Market: Key Mergers, Acquisitions and Partnerships, APAC, 2015–2021
8. Total Molecular Diagnostics Market: Revenue Forecast, APAC, 2014–2021
9. Total Molecular Diagnostics Market: Percent Revenue by Country, APAC, 2016
10. Total Molecular Diagnostics Market: Percent Revenue Forecast by Country, APAC, 2021
11. Total Molecular Diagnostics Market: Key Market Participants, APAC, 2016
12. Total Molecular Diagnostics Market: Percent Revenue by Companies, APAC, 2016
13. Total Molecular Diagnostics Market: Snapshot of Emerging Lifestyle Genetic Tests, APAC, 2016
14. Total Molecular Diagnostics Market: MDx Tests in Different Applications, APAC, 2016
15. Infectious Disease Segment: Revenue Forecast, APAC, 2014–2021
16. Oncology Segment: Revenue Forecast, APAC, 2014–2021
17. Genetic Disorders Segment: Revenue Forecast, APAC, 2014–2021
18. Pharmacogenomics Segment: Revenue Forecast, APAC, 2014–2021
19. Molecular Diagnostics Market: Revenue Forecast, China, 2014–2021
20. Molecular Diagnostics Market: Revenue Forecast, South Korea, 2014–2021
21. Molecular Diagnostics Market: Revenue Forecast, India, 2014–2021
22. Molecular Diagnostics Market: Revenue Forecast, Japan, 2014–2021
23. Molecular Diagnostics Market: Revenue Forecast, Australia, 2014–2021
24. Molecular Diagnostics Market: Revenue Forecast, Australia, 2014–2021
25. Molecular Diagnostics Market: Revenue Forecast, Indonesia, 2014–2021
26. Molecular Diagnostics Market: Revenue Forecast, Malaysia, 2014–2021
27. Molecular Diagnostics Market: Revenue Forecast, Thailand, 2014–2021
28. Molecular Diagnostics Market: Revenue Forecast, Singapore, 2014–2021
29. Molecular Diagnostics Market: Revenue Forecast, Philippines, 2014–2021
30. Molecular Diagnostics Market: Revenue Forecast, Vietnam, 2014–2021



Related Research

Release Date : 19-Jun-17

Region : Asia Pacific

Release Date : 02-Dec-16

Region : Asia Pacific

Release Date : 14-Nov-16

Region : Asia Pacific

Release Date : 11-Nov-16

Region : Asia Pacific

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.